Showing 1 - 2 results of 2 for search 'Hirotaka Matsumoto, MD', query time: 0.02s
Refine Results
-
1
Clinical Impact of Pre-Existing Autoantibodies in Patients With SCLC Treated With Immune Checkpoint Inhibitor: A Multicenter Prospective Observational Study by Yuki Sato, MD, Satoru Fujiwara, MD, Akito Hata, MD, Yoko Kida, MD, Takahiro Masuda, MD, Hisanori Amimoto, MD, Hirotaka Matsumoto, MD, Kotoko Miyoshi, MD, Kojiro Otsuka, MD, PhD, Keisuke Tomii, MD, PhD
Published 2023-12-01
Article -
2
First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%: Real-World Study Including Older Patients in Japan by Yasushi Goto, MD, PhD, Atsuhisa Tamura, MD, PhD, Hirotaka Matsumoto, MD, Kazutoshi Isobe, MD, PhD, Tomohiro Ozaki, MD, Melissa L. Santorelli, PhD, MPH, Kazuko Taniguchi, MS, Tetsu Kamitani, MD, PhD, Masato Irisawa, PhD, Kingo Kanda, MPharm, Machiko Abe, MS, Thomas Burke, PharmD, PhD, Hiroshi Nokihara, MD, PhD
Published 2022-09-01
Article